Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Thayer WO"" wg kryterium: Autor


Wyświetlanie 1-9 z 9
Tytuł :
Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8 cells.
Autorzy :
McBrien JB; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Mavigner M; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Franchitti L; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Smith SA; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
White E; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Tharp GK; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Walum H; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Busman-Sahay K; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.
Aguilera-Sandoval CR; International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Thayer WO; International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Spagnuolo RA; International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Kovarova M; International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Wahl A; International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Cervasi B; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Margolis DM; International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; University of North Carolina HIV Cure Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Vanderford TH; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Carnathan DG; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Paiardini M; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Lee JH; NantKwest, Culver City, CA, USA.
Safrit JT; NantKwest, Culver City, CA, USA.
Bosinger SE; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Estes JD; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Derdeyn CA; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Garcia JV; International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Kulpa DA; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Chahroudi A; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Emory + Children's Center for Childhood Infections and Vaccines, Atlanta, GA, USA.
Silvestri G; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA. .; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA. .
Pokaż więcej
Źródło :
Nature [Nature] 2020 Feb; Vol. 578 (7793), pp. 154-159. Date of Electronic Publication: 2020 Jan 22.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Virus Replication*/immunology
CD8-Positive T-Lymphocytes/*immunology
Interleukin-15/*agonists
Simian Immunodeficiency Virus/*physiology
Animals ; CD4-Positive T-Lymphocytes/virology ; HIV Infections/immunology ; HIV Infections/virology ; Humans ; Interleukin-15/immunology ; Lymphocyte Depletion ; Macaca mulatta ; Mice ; Simian Acquired Immunodeficiency Syndrome/immunology ; Simian Acquired Immunodeficiency Syndrome/virology ; Virus Latency
Czasopismo naukowe
Tytuł :
Author Correction: Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8 cells.
Autorzy :
McBrien JB; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Mavigner M; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Franchitti L; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Smith SA; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
White E; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Tharp GK; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Walum H; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Busman-Sahay K; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.
Aguilera-Sandoval CR; International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Thayer WO; International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Spagnuolo RA; International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Kovarova M; International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Wahl A; International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Cervasi B; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Margolis DM; International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; University of North Carolina HIV Cure Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Vanderford TH; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Carnathan DG; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Paiardini M; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Lee JH; NantKwest, Culver City, CA, USA.
Safrit JT; NantKwest, Culver City, CA, USA.
Bosinger SE; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Estes JD; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Derdeyn CA; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Garcia JV; International Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Kulpa DA; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Chahroudi A; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Emory + Children's Center for Childhood Infections and Vaccines, Atlanta, GA, USA.
Silvestri G; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA. .; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA. .
Pokaż więcej
Źródło :
Nature [Nature] 2020 Feb; Vol. 578 (7796), pp. E21.
Typ publikacji :
Published Erratum
Tytuł :
Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients.
Autorzy :
Deuse T; Department of Surgery, Division of Cardiothoracic Surgery, Transplant and Stem Cell Immunobiology-Lab, University of California San Francisco, San Francisco, CA, USA.
Hu X; Department of Surgery, Division of Cardiothoracic Surgery, Transplant and Stem Cell Immunobiology-Lab, University of California San Francisco, San Francisco, CA, USA.; Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany.; Cardiovascular Research Center Hamburg and DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Luebeck, Hamburg, Germany.
Gravina A; Department of Surgery, Division of Cardiothoracic Surgery, Transplant and Stem Cell Immunobiology-Lab, University of California San Francisco, San Francisco, CA, USA.
Wang D; Department of Surgery, Division of Cardiothoracic Surgery, Transplant and Stem Cell Immunobiology-Lab, University of California San Francisco, San Francisco, CA, USA.; Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany.
Tediashvili G; Department of Surgery, Division of Cardiothoracic Surgery, Transplant and Stem Cell Immunobiology-Lab, University of California San Francisco, San Francisco, CA, USA.; Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany.; Cardiovascular Research Center Hamburg and DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Luebeck, Hamburg, Germany.
De C; Division of Infectious Diseases, UNC Center for AIDS Research, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Thayer WO; Division of Infectious Diseases, UNC Center for AIDS Research, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Wahl A; Division of Infectious Diseases, UNC Center for AIDS Research, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Garcia JV; Division of Infectious Diseases, UNC Center for AIDS Research, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Reichenspurner H; Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany.; Cardiovascular Research Center Hamburg and DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Luebeck, Hamburg, Germany.
Davis MM; Howard Hughes Medical Institute, Institute for Immunity, Transplantation and Infection, and Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Lanier LL; Department of Microbiology and Immunology and the Parker Institute for Cancer Immunotherapy, University of California San Francisco, San Francisco, California, USA.
Schrepfer S; Department of Surgery, Division of Cardiothoracic Surgery, Transplant and Stem Cell Immunobiology-Lab, University of California San Francisco, San Francisco, CA, USA. .
Pokaż więcej
Źródło :
Nature biotechnology [Nat Biotechnol] 2019 Mar; Vol. 37 (3), pp. 252-258. Date of Electronic Publication: 2019 Feb 18.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Differentiation/*immunology
Graft Rejection/*immunology
HLA Antigens/*genetics
Induced Pluripotent Stem Cells/*transplantation
Animals ; Cell Differentiation/genetics ; Graft Rejection/genetics ; HLA Antigens/immunology ; Histocompatibility Antigens Class I/genetics ; Humans ; Mice ; Myocytes, Cardiac/chemistry ; Myocytes, Cardiac/metabolism ; Myocytes, Cardiac/pathology ; Transplantation, Homologous/methods
Czasopismo naukowe
Tytuł :
T cells establish and maintain CNS viral infection in HIV-infected humanized mice.
Autorzy :
Honeycutt JB; Division of Infectious Diseases, Center for AIDS Research (CFAR), University of North Carolina at Chapel Hill (UNC-CH), School of Medicine, Chapel Hill, North Carolina, USA.
Liao B; Division of Infectious Diseases, Center for AIDS Research (CFAR), University of North Carolina at Chapel Hill (UNC-CH), School of Medicine, Chapel Hill, North Carolina, USA.; Department of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
Nixon CC; Division of Infectious Diseases, Center for AIDS Research (CFAR), University of North Carolina at Chapel Hill (UNC-CH), School of Medicine, Chapel Hill, North Carolina, USA.
Cleary RA; Division of Infectious Diseases, Center for AIDS Research (CFAR), University of North Carolina at Chapel Hill (UNC-CH), School of Medicine, Chapel Hill, North Carolina, USA.
Thayer WO; Division of Infectious Diseases, Center for AIDS Research (CFAR), University of North Carolina at Chapel Hill (UNC-CH), School of Medicine, Chapel Hill, North Carolina, USA.
Birath SL; Division of Infectious Diseases, Center for AIDS Research (CFAR), University of North Carolina at Chapel Hill (UNC-CH), School of Medicine, Chapel Hill, North Carolina, USA.
Swanson MD; Division of Infectious Diseases, Center for AIDS Research (CFAR), University of North Carolina at Chapel Hill (UNC-CH), School of Medicine, Chapel Hill, North Carolina, USA.
Sheridan P; Department of Nutrition, UNC-CH, Gillings School of Global Public Health, Chapel Hill, North Carolina, USA.
Zakharova O; Division of Infectious Diseases, Center for AIDS Research (CFAR), University of North Carolina at Chapel Hill (UNC-CH), School of Medicine, Chapel Hill, North Carolina, USA.
Prince F; Division of Infectious Diseases, Center for AIDS Research (CFAR), University of North Carolina at Chapel Hill (UNC-CH), School of Medicine, Chapel Hill, North Carolina, USA.
Kuruc J; Division of Infectious Diseases, Center for AIDS Research (CFAR), University of North Carolina at Chapel Hill (UNC-CH), School of Medicine, Chapel Hill, North Carolina, USA.
Gay CL; Division of Infectious Diseases, Center for AIDS Research (CFAR), University of North Carolina at Chapel Hill (UNC-CH), School of Medicine, Chapel Hill, North Carolina, USA.
Evans C; Division of Infectious Diseases, Center for AIDS Research (CFAR), University of North Carolina at Chapel Hill (UNC-CH), School of Medicine, Chapel Hill, North Carolina, USA.
Eron JJ; Division of Infectious Diseases, Center for AIDS Research (CFAR), University of North Carolina at Chapel Hill (UNC-CH), School of Medicine, Chapel Hill, North Carolina, USA.
Wahl A; Division of Infectious Diseases, Center for AIDS Research (CFAR), University of North Carolina at Chapel Hill (UNC-CH), School of Medicine, Chapel Hill, North Carolina, USA.
Garcia JV; Division of Infectious Diseases, Center for AIDS Research (CFAR), University of North Carolina at Chapel Hill (UNC-CH), School of Medicine, Chapel Hill, North Carolina, USA.
Pokaż więcej
Źródło :
The Journal of clinical investigation [J Clin Invest] 2018 Jul 02; Vol. 128 (7), pp. 2862-2876. Date of Electronic Publication: 2018 Jun 04.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Brain/*immunology
Brain/*virology
HIV Infections/*immunology
HIV Infections/*virology
T-Lymphocytes/*immunology
Animals ; Anti-HIV Agents/pharmacology ; Brain/pathology ; DNA, Viral/genetics ; DNA, Viral/metabolism ; Disease Models, Animal ; Female ; HIV Infections/drug therapy ; HIV-1/genetics ; HIV-1/isolation & purification ; Humans ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Inbred NOD ; Mice, SCID ; Myeloid Cells/immunology ; Myeloid Cells/pathology ; Myeloid Cells/virology ; RNA, Viral/genetics ; RNA, Viral/metabolism ; T-Lymphocytes/pathology ; T-Lymphocytes/virology
Czasopismo naukowe
Tytuł :
HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy.
Autorzy :
Honeycutt JB; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina, School of Medicine, Chapel Hill, North Carolina, USA.
Thayer WO; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina, School of Medicine, Chapel Hill, North Carolina, USA.
Baker CE; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina, School of Medicine, Chapel Hill, North Carolina, USA.
Ribeiro RM; Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico, USA.
Lada SM; Veterans Affairs, San Diego Healthcare System, San Diego, California, USA.
Cao Y; Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico, USA.
Cleary RA; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina, School of Medicine, Chapel Hill, North Carolina, USA.
Hudgens MG; Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA.
Richman DD; Veterans Affairs, San Diego Healthcare System, San Diego, California, USA.; Department of Medicine, University of California, San Diego, San Diego, California, USA.; Department of Pathology, University of California, San Diego, San Diego, California, USA.
Garcia JV; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina, School of Medicine, Chapel Hill, North Carolina, USA.
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2017 May; Vol. 23 (5), pp. 638-643. Date of Electronic Publication: 2017 Apr 17.
Typ publikacji :
Journal Article
MeSH Terms :
HIV Infections/*virology
HIV-1/*physiology
Macrophages/*virology
Animals ; Anti-HIV Agents/therapeutic use ; Antiretroviral Therapy, Highly Active ; Bone Marrow ; DNA, Viral ; Electrophoresis, Gel, Pulsed-Field ; HIV Infections/drug therapy ; HIV-1/genetics ; Hematopoietic Stem Cell Transplantation ; Humans ; Immunohistochemistry ; Lactones ; Leukocytes, Mononuclear ; Liver ; Macrophages, Alveolar/virology ; Mice ; Nuclear Receptor Subfamily 4, Group A, Member 2 ; Phenols ; RNA, Viral ; Spleen ; T-Lymphocytes ; Viral Load ; Virus Latency ; Virus Replication
Czasopismo naukowe
Tytuł :
In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
Autorzy :
Tsai P; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill School of Medicine, 120 Mason Farm Rd., CB 7042, Genetic Medicine Building 2043, Chapel Hill, NC, 27599, USA.
Wu G; Merck Research Laboratories, Merck & Co., Inc., West Point, PA, 19486, USA.
Baker CE; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill School of Medicine, 120 Mason Farm Rd., CB 7042, Genetic Medicine Building 2043, Chapel Hill, NC, 27599, USA.
Thayer WO; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill School of Medicine, 120 Mason Farm Rd., CB 7042, Genetic Medicine Building 2043, Chapel Hill, NC, 27599, USA.
Spagnuolo RA; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill School of Medicine, 120 Mason Farm Rd., CB 7042, Genetic Medicine Building 2043, Chapel Hill, NC, 27599, USA.
Sanchez R; Merck Research Laboratories, Merck & Co., Inc., West Point, PA, 19486, USA.
Barrett S; Merck Research Laboratories, Merck & Co., Inc., West Point, PA, 19486, USA.
Howell B; Merck Research Laboratories, Merck & Co., Inc., West Point, PA, 19486, USA.
Margolis D; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill School of Medicine, 120 Mason Farm Rd., CB 7042, Genetic Medicine Building 2043, Chapel Hill, NC, 27599, USA.
Hazuda DJ; Merck Research Laboratories, Merck & Co., Inc., West Point, PA, 19486, USA.
Archin NM; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill School of Medicine, 120 Mason Farm Rd., CB 7042, Genetic Medicine Building 2043, Chapel Hill, NC, 27599, USA. .
Garcia JV; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill School of Medicine, 120 Mason Farm Rd., CB 7042, Genetic Medicine Building 2043, Chapel Hill, NC, 27599, USA. .
Pokaż więcej
Źródło :
Retrovirology [Retrovirology] 2016 May 21; Vol. 13 (1), pp. 36. Date of Electronic Publication: 2016 May 21.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-HIV Agents/*therapeutic use
CD4-Positive T-Lymphocytes/*virology
DNA, Viral/*metabolism
HIV-1/*drug effects
Hydroxamic Acids/*therapeutic use
Indoles/*therapeutic use
RNA, Viral/*metabolism
Virus Latency/*drug effects
Acetylation ; Animals ; Anti-HIV Agents/pharmacology ; CD4-Positive T-Lymphocytes/drug effects ; HIV Infections/drug therapy ; HIV Infections/virology ; HIV-1/genetics ; HIV-1/physiology ; Histone Deacetylase Inhibitors/pharmacology ; Histone Deacetylase Inhibitors/therapeutic use ; Histones/metabolism ; Humans ; Hydroxamic Acids/pharmacology ; Indoles/pharmacology ; Leukocytes, Mononuclear/drug effects ; Leukocytes, Mononuclear/metabolism ; Mice ; Mice, Transgenic ; Panobinostat ; RNA, Viral/blood ; Virus Activation/drug effects ; Virus Replication/drug effects
Czasopismo naukowe
Tytuł :
CD19xCD3 DART protein mediates human B-cell depletion in vivo in humanized BLT mice.
Autorzy :
Tsai P; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill School of Medicine , Chapel Hill, North Carolina, USA.
Thayer WO; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill School of Medicine , Chapel Hill, North Carolina, USA.
Liu L; MacroGenics, Inc. , Rockville, Maryland, USA.
Silvestri G; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Department of Pathology and Laboratory Medicine, Emory University School of Medicine , Atlanta, Georgia, USA.
Nordstrom JL; MacroGenics, Inc. , Rockville, Maryland, USA.
Garcia JV; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill School of Medicine , Chapel Hill, North Carolina, USA.
Pokaż więcej
Źródło :
Molecular therapy oncolytics [Mol Ther Oncolytics] 2016 Mar 02; Vol. 3, pp. 15024. Date of Electronic Publication: 2016 Mar 02 (Print Publication: 2016).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Correction: Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission.
Autorzy :
Kovarova M
Council OD
Date AA
Long JM
Nochi T
Belshan M
Shibata A
Vincent H
Baker CE
Thayer WO
Kraus G
Lachaud-Durand S
Williams P
Destache CJ
Garcia JV
Pokaż więcej
Źródło :
PLoS pathogens [PLoS Pathog] 2015 Oct 16; Vol. 11 (10), pp. e1005170. Date of Electronic Publication: 2015 Oct 16 (Print Publication: 2015).
Typ publikacji :
Published Erratum
Tytuł :
Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission.
Autorzy :
Kovarova M; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, United States of America.
Council OD; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, United States of America.
Date AA; Department of Pharmacy Practice, Creighton University School of Pharmacy and Health Professions, Omaha, Nebraska, United States of America.
Long JM; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, United States of America.
Nochi T
Belshan M; Department of Pharmacy Practice, Creighton University School of Pharmacy and Health Professions, Omaha, Nebraska, United States of America.
Shibata A; Department of Pharmacy Practice, Creighton University School of Pharmacy and Health Professions, Omaha, Nebraska, United States of America.
Vincent H; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, United States of America.
Baker CE; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, United States of America.
Thayer WO; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, United States of America.
Kraus G; Janssen Research and Development, Beerse, Belgium.
Lachaud-Durand S; Janssen Research and Development, Beerse, Belgium.
Williams P; Janssen Research and Development, Beerse, Belgium.
Destache CJ; Department of Pharmacy Practice, Creighton University School of Pharmacy and Health Professions, Omaha, Nebraska, United States of America.
Garcia JV; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, United States of America.
Pokaż więcej
Źródło :
PLoS pathogens [PLoS Pathog] 2015 Aug 13; Vol. 11 (8), pp. e1005075. Date of Electronic Publication: 2015 Aug 13 (Print Publication: 2015).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
HIV Infections/*prevention & control
Rilpivirine/*administration & dosage
Animals ; Anti-HIV Agents/administration & dosage ; Chromatography, High Pressure Liquid ; Disease Models, Animal ; HIV Infections/transmission ; HeLa Cells ; Humans ; Mice ; Nanoparticles/administration & dosage ; Vaginal Creams, Foams, and Jellies/pharmacology
Czasopismo naukowe
    Wyświetlanie 1-9 z 9

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies